Results 181 to 190 of about 20,867 (266)

In silico prediction and structural characterization of multifunctional bioactive peptides released from olive proteins

Journal of the Science of Food and Agriculture, Volume 106, Issue 9, Page 5463-5482, July 2026.
Abstract BACKGROUND Olive (Olea europaea L.) byproducts, such as seeds and leaves, are abundant agro‐industrial residues and represent underexplored protein sources with potential health relevance. However, the repertoire of bioactive peptides that may be released from olive proteins during gastrointestinal digestion remains poorly characterized.
Teresa Gonzalez‐de la Rosa, Luna Barrera‐Chamorro, Africa Fernandez‐Prior, Elvira Marquez‐Paradas, Maria Torrecillas‐Lopez, Fernando Rivero‐Pino, Sergio Montserrat‐de la Paz   +6 more
wiley   +1 more source

Food noise: integrating experience and evidence. [PDF]

Nutr Diabetes
Prakash R, Khan A.
europepmc   +1 more source

Could Incretin‐Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT‐5

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6475-6477, August 2026.
Jacopo Ciaffi, Roberto Caporali, Francesco Ursini   +2 more
wiley   +1 more source

Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilance. [PDF]

Int J Mol Sci
Marin RC, Vesa CM, Tit DM, Radu AF, Bungau GS.   +4 more
europepmc   +1 more source

Fatty Pancreas and Risk of Type 2 Diabetes, Chronic Kidney Disease and Cardiovascular Events: Evidence From a Population‐Based Cohort

United European Gastroenterology Journal, Volume 14, Issue 6, July 2026.
ABSTRACT Background Fatty pancreas is a metabolically active ectopic fat depot, but its cardiometabolic implications have been assessed using heterogeneous thresholds. We investigated the association of fatty pancreas, quantified using MRI‐derived proton density fat fraction (PDFF) and categorised according to 2026 international consensus thresholds ...
Nicola Pugliese, Oveis Jamialahmadi, Arturo Cesaro, Valentina Flagiello, Rosellina M. Mancina, Alessio Aghemo, Stefano Romeo   +6 more
wiley   +1 more source

β-cell recovery revisited: Is prediabetes remission driven by insulin sensitivity or β-cell function? [PDF]

J Diabetes Investig
Lee J, Yoon KH.
europepmc   +1 more source

Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review

Journal of Diabetes, Volume 18, Issue 7, July 2026.
RCTs of incretin‐based treatment show effective weight loss and glycemic benefit, as well as improved CV outcomes. There is, however, uncertainty as to whether the RCTs translate to real‐world outcomes. This narrative review suggests real‐world outcomes are comparable to RCTs after accounting for submaximal dosing and high discontinuation rates ...
Zachary Bloomgarden
wiley   +1 more source

A Bibliometric Analysis Review of the Top 50 Most Cited Articles on Incretin-Based Therapy for Weight Reduction and Diabetes Management. [PDF]

Cureus
Alsaygh EF, Aljarboa AM, Alhazmi AA, Alhazmi AS, Alraddadi OA, Althagafi AA, Alhojele MF.   +6 more
europepmc   +1 more source

The attenuated incretin effect is associated with glucose intolerance in patients with hepatitis B-related acute-on-chronic liver failure. [PDF]

Front Physiol
Li M, Hu H, Liu Y, Wu X, Zhang Y, Li Y, Yang F, Li Y, Lin S.   +8 more
europepmc   +1 more source